or Try an Advanced Search...

    Disorders Stocks List

    Symbol Grade Name % Change
    CGTX D Cognition Therapeutics, Inc. -2.53
    KROS D Keros Therapeutics, Inc. 6.08
    CORT D Corcept Therapeutics Incorporated -2.15
    MYMD D MyMD Pharmaceuticals, Inc. 2.46
    LFST D LifeStance Health Group, Inc. 1.99
    FULC D Fulcrum Therapeutics, Inc. 1.31
    CPRX D Catalyst Pharmaceutical Partners, Inc. -2.00
    IONS F Ionis Pharmaceuticals, Inc. -2.60
    BAX F Baxter International Inc. -0.05
    OVID F Ovid Therapeutics Inc. -0.33
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Medical Care Facilities Medical Instruments & Supplies
    Related Stock Lists: Biopharmaceutical Medicine Organ Systems Pharmaceutical Cushing's Syndrome Depression Diabetes Dystrophy Epilepsy Genodermatoses Geriatrics Health Sciences Medication Neurological Disorders Psychiatric Diagnosis Rare Diseases Syndromes Abnormal Psychology Acromegaly Age Related Diseases

    Related ETFs - A few ETFs which own one or more of the above listed Disorders stocks.

    Symbol Grade Name Weight
    PBE C PowerShares Dynamic Biotech & Genome 12.9
    BBH B Market Vectors Biotech ETF 10.59
    FBT D First Trust Amex Biotech Index Fund 10.58
    IBB C iShares Nasdaq Biotechnology Index Fund 10.32
    IBBQ C Invesco Nasdaq Biotechnology ETF 10.27
    View all Disorders ETFs...
    Compare ETFs
    Compare FBT to IBB Compare PBE to BBH Compare PBE to IBBQ

        Disorders Stocks Recent News

        Date Stock Title
        May 3 KROS Keros Therapeutics files automatic mixed shelf
        May 3 BAX Baxter International Inc. (NYSE:BAX) Q1 2024 Earnings Call Transcript
        May 3 BAX Is There An Opportunity With Baxter International Inc.'s (NYSE:BAX) 46% Undervaluation?
        May 3 CORT Corcept Therapeutics First Quarter 2024 Earnings: Beats Expectations
        May 3 BAX Baxter International Inc (BAX) Q1 2024 Earnings Call Transcript Highlights: Strong Start with ...
        May 2 CORT The Analyst Verdict: Corcept Therapeutics In The Eyes Of 4 Experts
        May 2 CORT Corcept (CORT) Q1 Earnings & Revenues Surpass Estimates
        May 2 BAX Baxter International Inc. 2024 Q1 - Results - Earnings Call Presentation
        May 2 BAX Compared to Estimates, Baxter (BAX) Q1 Earnings: A Look at Key Metrics
        May 2 CORT Corcept Therapeutics Incorporated (NASDAQ:CORT) Q1 2024 Earnings Call Transcript
        May 2 BAX Baxter International Inc. (BAX) Q1 2024 Earnings Call Transcript
        May 2 BAX Baxter (BAX) Q1 Earnings Beat Estimates, '24 EPS View Raised
        May 2 CPRX Collegium Pharmaceutical (COLL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
        May 2 BAX Baxter International Inc (BAX) Surpasses Q1 Earnings and Revenue Estimates
        May 2 BAX Baxter International (BAX) Q1 Earnings and Revenues Surpass Estimates
        May 2 CORT Q1 2024 Corcept Therapeutics Inc Earnings Call
        May 2 BAX Baxter Non-GAAP EPS of $0.65 beats by $0.04, revenue of $3.59B beats by $40M
        May 2 BAX Baxter Reports First-Quarter 2024 Results
        May 2 CORT Corcept Therapeutics Inc (CORT) Q1 2024 Earnings Call Transcript Highlights: Strong Growth Amid ...
        May 2 CORT Corcept Therapeutics Incorporated (CORT) Q1 2024 Earnings Call Transcript
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Medical Care Facilities Medical Instruments & Supplies
        Related Stock Lists: Biopharmaceutical Medicine Pain Biotechnology Epilepsy Schizophrenia Alzheimer's Disease Cardiovascular Disease Clinical Development Clinical Research Cognitive Disorders Inflammation Insomnia Macular Degeneration Major Depressive Disorder Medication Movement Disorders Neuroscience Ophthalmology Parkinson's Disease
        Disorders

        Disorder may refer to randomness, non-order, or no intelligible pattern. Disorder may also refer to:

        More about Disorders
        Browse All Tags